Close mobile menu×
Close mobile menu

Edward V. Nunes, MD

Board Certifications: 
Addiction Psychiatry, Psychiatry
Expertise in: 
General Psychiatry / Psychology, Depression, Anxiety Disorders
Accepting New Patients

Appointments

Phone Appointments

New and Existing Patients: 
(212) 579-0339

myColumbiaDoctors

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

America's Top Doctor
NY Top Doctor

Board Certifications

  • Addiction Psychiatry
  • Psychiatry

Clinical Expertise

  • General Psychiatry / Psychology
  • Depression
  • Anxiety Disorders
  • Alcoholism
  • Substance Use
  • Depression
  • Alcohol Use Disorders
  • Opioid Use Disorders

Education & Training

  • University of Connecticut School of Medicine
  • Internship: St. Elizabeth's Medical Center, Boston
  • Residency: Columbia Presbyterian Medical Center, NY
  • Fellowship: New York State Psychiatric Institute

About Edward Nunes

Dr. Nunes is a Professor of Psychiatry, and Principal Investigator of the Greater New York Node of the National Institute on Drug Abuse (NIDA) clinical Trials Network as well as other NIDA funded studies on behavioral and medication treatments for substance dependence and related psychiatric disorders. Interests and ongoing studies include treatments for cocaine dependence in general, heroin and other opioid dependence, for nicotine dependence in general, and for addicted patients with co-occurring psychiatric disorders including depression, and post-traumatic stress disorder. Types of treatment under study include medication treatments (naltrexone, buprenorphine, mirtazapine) as well as behavioral and psychotherapeutic approaches and computer-delivered treatments. Dr. Nunes also studies the challenges involved in implementing evidence-based treatments for substance use disorders in real-world community-based treatments settings. Dr. Nunes also serves on the American Board of Addiction Medicine, Co-Chair of the Columbia/ New York State Psychiatric Institute’s Institutional Review Board, and has been appointed to the National Advisory Council on Drug Abuse.

Academic Titles

  • Professor of Psychiatry at CUMC

Hospital Affiliations

  • NewYork-Presbyterian/Columbia

Gender

  • Male

Contact & Locations

1
617 West End Avenue
Apartment 1B
New York, New York 10024
Phone:
(212) 579-0339
Primary

Research

Grants

EVALUATION OF SAFETY AND PHARMACOKINETICS OF NALTREXONE IMPLANT (Federal Gov)

Sep 15 2018 - Aug 31 2023

INVESTIGATION OF THE NMDA ANTAGONIST KETAMINE AS A TREATMENT FOR TINNITUS (Federal Gov)

Jan 1 2019 - Jun 14 2022

COMPREHENSIVE CBT VIA RESET FOR A HUB AND SPOKE MAT SYSTEM OF CARE (Federal Gov)

Sep 20 2018 - Sep 19 2021

MISSING DATA MATTERS: SUBSTANCE USE DISORDER CLINICAL TRIALS (Federal Gov)

Aug 15 2018 - Apr 30 2021

FY 2018 OPIOID STATE TARGETED RESPONSE TECHNICAL ASSISTANCE (STR TA) (Federal Gov)

Feb 1 2018 - Jan 31 2020

FY 2018 OPIOID STATE TARGETED RESPONSE TECHNICAL ASSISTANCE (STR TA) (Federal Gov)

Feb 1 2018 - Jan 31 2020

TRAINING MEDICAL AND DENTAL STUDENTS IN SBIRT (Federal Gov)

Sep 30 2015 - Sep 29 2019

PROVIDERS CLINICAL SUPPORT SYSTEM FOR MEDICATION ASSISTED TREATMENT (PCSS-MAT) - TRAINING AND IMPLEMENTATION (Federal Gov)

Aug 1 2016 - Jul 31 2019

RISK AND BENEFITS OF OVERDOSE EDUCATION AND NALOXONE PRESCRIBING TO HEROIN USERS (Federal Gov)

Sep 15 2014 - Aug 31 2018

CLINICAL TRIALS NETWORK: GREATER NEW YORK NODE (CTN-0051) (Federal Gov)

Jun 1 2017 - May 31 2018

CLINICAL TRIALS NETWORK: GREATER NEW YORK NODE (CTN-0068) (Federal Gov)

Jun 1 2017 - May 31 2018

DRUG ABUSE TREATMENT DEVELOPMENT AND RESEARCH MENTORING (Federal Gov)

May 1 2007 - Apr 30 2018

RISK AND BENEFITS OF OVERDOSE EDUCATION AND NALOXONE PRESCRIBING TO HEROIN USERS (Federal Gov)

Sep 15 2014 - Feb 28 2018

A GAME-BASED INTERVENTION FOR OPIOID USE DISORDER (Private)

Jul 1 2017 - Dec 31 2017

RISK AND BENEFITS OF OVERDOSE EDUCATION AND NALOXONE PRESCRIBING TO HEROIN USERS (Federal Gov)

Sep 15 2014 - Aug 31 2017

SHARED PHARMACOTHERAPEUTIC STRATEGIES FOR CANNABINOID & OPIOID USE DISORDERS (Federal Gov)

Sep 1 2014 - Jun 30 2017

RISK AND BENEFITS OF OVERDOSE EDUCATION AND NALOXONE PRESCRIBING TO HEROIN USERS (Federal Gov)

Sep 15 2014 - Aug 31 2016